Advancing Services & Software for INDs: How to Expedite IND Filing with a Subscription Model Blog Post
新薬臨床試験申請開始（IND）のプロセスや方法を選択する際、予算、ソフトウェア、人的サポートなど、決定しなければならない多くの要素があります。budget, software, personnel support, and more. To further complicate matters,…
D360 Scientific Informatics Discovery Platform: User Stories Blog Post
Transcript: I’ve joined companies both blueprint medicines and score therapeutics is one of the first employees with no infrastructure in place. So I have with chemists and biologists evaluated products…
Upping the Ante for Predicting the Success of Alzheimer Disease Treatments Blog Post
By Hugo Geerts, PhD, Piet van der Graaf, PharmD, PhD Over the past 20 years, less than a handful of completed Phase III Alzheimer disease (AD) clinical trials have been…
Certara to Report Fourth Quarter and Full Year 2023 Financial Results on February 29th, 2024 and Participate in the Barclays 26th Annual Global Healthcare Conference Blog Post
PRINCETON, N.J., Feb. 01, 2024 (GLOBE NEWSWIRE) — Certara, Inc. バイオシミュレーションのグローバルリーダーであるサターラ（Nasdaq：CERT) はCERT), a global leader in biosimulation, today announced that it will release financial results for the fourth quarter and…
Phuse US Connect Blog Post
Conference: Phuse US Connect Date: March 16-19, 2025 Location: Orlando, Florida Booth: A Sponsor: Platinum Meet us there Where to hear Certara insights and Expertise Monday, March 17, 4:30-5pm ET...
Navigating Market Access for Healthcare Products: The Power of the Global Value Dossier Blog Post
このブログでは、グローバル・バリュー・ドシエ（GVD）とは何かをわかりやすく解説し、BaseCaseがどのようにインタラクティブな価値提案ツールの作成をサポートできるかをご紹介します。
Understanding the Role of Your Discovery Asset’s Target Product Profile Blog Post
If you work at a biotechnology start-up, you’re probably excited about your compound assets, particularly if your development program has a single asset. Unfortunately, navigating the ocean of opportunity can…
